Trial Search Results

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

The rod-cone dystrophies (often referred to as retinitis pigmentosa (RP)) are a clinically and genetically heterogeneous group of disorders in which there is progressive loss of rod and later cone photoreceptor function leading to severe visual impairment. RP usually occurs as an isolated retinal disorder, but it may also be seen in association with systemic abnormalities.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

MeiraGTx UK II Ltd

Collaborator: Janssen, LP

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Males & Females aged 5 years or older

   - Have RPGR-associated retinal dystrophy

   - Are able to give informed consent or assent, with the guidance of their
   parent/guardian where appropriate

   - Are able to undertake age-appropriate clinical assessments as specified in the
   protocol

   - Have genetic mutation within the RPGR gene confirmed by an accredited lab or research
   lab.

Exclusion Criteria:

   - Are unable or unwilling to undertake consent or clinical testing

Ages Eligible for Study

5 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting